"At the Clinical Trials Center, we pride ourselves on innovative medical research that is expanding the boundaries of biomedical knowledge. Our trained staff conducts industry sponsored clinical trial research in both device and drug (Phases II -IV) in a wide-range of therapeutic areas. This provides area residents local access to services associated with these products, without the need to travel outside West Virginia."

During the past decade, CAMC Clinical Trials Center conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 5 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CAMC Clinical Trials Center" #1 sponsor was "AstraZeneca" with 3 trials, followed by "Exact Sciences Corporation" with 3 trials sponsored, "Spectranetics Corporation" with 2 trials sponsored, "AlloCure Inc." with 1 trials sponsored and "Boehringer Ingelheim" with 1 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CAMC Clinical Trials Center" #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Bard Ltd" with 1 trials as a collaborator, "Boston Medical Center" with 1 trials as a collaborator and "Boston Scientific Corporation" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "CAMC Clinical Trials Center" are "Cancer" (2 trials), "Colorectal Cancer" (2 trials), "Hypertension" (2 trials), "Prostate Cancer" (2 trials) and "Acute Kidney Injury" (1 trials). Many other conditions were trialed in "CAMC Clinical Trials Center" in a lesser frequency.

Most popular intervention types in "CAMC Clinical Trials Center" are "Drug" (9 trials), "Device" (7 trials), "Other" (4 trials), "Biological" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "AC2993" (3 trials), "Blood Sample Collection" (2 trials), "AC607" (1 trials) and "Apixaban 2.5 MG" (1 trials). Other intervention names were less common.

The vast majority of trials in "CAMC Clinical Trials Center" are 22 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "CAMC Clinical Trials Center". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in CAMC Clinical Trials Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in CAMC Clinical Trials Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".